MALAT1 and lung carcinoma: Reducing lncRNA-MALAT1 levels results in an increased chance of cancer cell migration and disease progression, suggesting that lncRNA-MALAT1 as a lung cancer marker may be a potential strategy for treating metastatic lung cancer.